{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:28:06Z","timestamp":1785407286597,"version":"3.56.0"},"reference-count":73,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4198\/en-US"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"published-print":{"date-parts":[[2025,12,11]]},"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a condition that predominantly affects the pulmonary arterial bed, leading to pulmonary vascular remodeling, progressive decrease in pulmonary arterial compliance, and increase in pulmonary vascular resistance. The symptoms of PAH are nonspecific, which often contributes to diagnostic challenges and significant delays in establishing the diagnosis. The investigation of PAH is extensive and involves thorough search for potential clinical conditions that may contribute to its development, as well as the exclusion of other causes of pulmonary hypertension. The proper hemodynamic definition of PAH requires right heart catheterization (RHC) and direct measurements of mean pulmonary artery pressure, pulmonary arterial wedge pressure, cardiac output, and pulmonary vascular resistance. Additionally, RHC allows the assessment of the severity of the disease and, in selected cases, the identification of patients with a positive pulmonary vascular vasoreactivity test. RHC also provides valuable longitudinal information for risk stratification and patient follow-up. In the current manuscript, we review the PAH diagnostic workup, including a detailed review of the most up-to-date recommendations for right RHC and patient risk stratification.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20250065","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T16:53:05Z","timestamp":1768841585000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of pulmonary arterial hypertension: a statement from the Brazilian Thoracic Association"],"prefix":"10.36416","author":[{"given":"Jose","family":"Leonidas Alves-Jr1","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Moreira Amado2","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02xfp8v59","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade de Bras\u00edlia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Amorim Correa3","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0176yjw32","id-type":"ROR","asserted-by":"publisher"}],"name":"Federal University of Minas Gerais"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"A F Thadeu Campos4","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/003hjp881","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Madre Teresa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio","family":"Fernandes1","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloara","family":"V M Ferreira5","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02k5swt12","id-type":"ROR","asserted-by":"publisher"}],"name":"Federal University of S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"B Gazzana6","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041yk2d64","id-type":"ROR","asserted-by":"publisher"}],"name":"Federal University of Rio Grande do Sul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Jorge Jac\u00f3 Rocha7","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01zqbjs16","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital de Messejana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Jardim1","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaquelina","family":"S Ota-Arakaki5","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02k5swt12","id-type":"ROR","asserted-by":"publisher"}],"name":"Federal University of S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pacheco Guimar\u00e3es4","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/003hjp881","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital Madre Teresa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Corso Pereira8","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04wffgt70","id-type":"ROR","asserted-by":"publisher"}],"name":"State University of Campinas (UNICAMP)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"P Ramos5","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02k5swt12","id-type":"ROR","asserted-by":"publisher"}],"name":"Federal University of S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Salibe-Filho1","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio","family":"Souza1","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Waetge9","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03490as77","id-type":"ROR","asserted-by":"publisher"}],"name":"Federal University of Rio de Janeiro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"K F Oliveira5","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02k5swt12","id-type":"ROR","asserted-by":"publisher"}],"name":"Federal University of S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.            Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D, et al. Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J. 2024;64(4):2401324. https:\/\/doi.org\/10.1183\/13993003.01324-2024","DOI":"10.1183\/13993003.01324-2024"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.            Leber L, Beaudet A, Muller A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulm Circ. 2021;11(1):2045894020977300. https:\/\/doi.org\/10.1038\/nrcardio.2017.84","DOI":"10.1177\/2045894020977300"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.            Lau EMT, Giannoulatou E, Celermajer DS, Humbert M. Epidemiology and treatment of pulmonary arterial hypertension. Nat Rev Cardiol. 2017;14(10):603-614. https:\/\/doi.org\/10.1038\/nrcardio.2017.84","DOI":"10.1038\/nrcardio.2017.84"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.            D\u2019Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-349. https:\/\/doi.org\/10.7326\/0003-4819-115-5-343","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.            Boucly A, Savale L, Ja\u00efs X, Bauer F, Bergot E, Bertoletti L, et al. Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2021;204(7):842-854. https:\/\/doi.org\/10.1164\/rccm.202009-3698OC","DOI":"10.1164\/rccm.202009-3698OC"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.            Alves JL Jr, Gavilanes F, Jardim C, Fernandes CJCDS, Morinaga LTK, Dias B, et al. Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases. Chest 2015;147(2):495-501. https:\/\/doi.org\/10.1378\/chest.14-1036","DOI":"10.1378\/chest.14-1036"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.            Humbert M, Guignabert C, Bonnet S, Dorfm\u00fcller P, Klinger JR, Nicolls MR, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1):1801887. https:\/\/doi.org\/10.1183\/13993003.01887-2018","DOI":"10.1183\/13993003.01887-2018"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.            Vonk Noordegraaf A, Westerhof BE, Westerhof N. The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension. J Am Coll Cardiol. 2017;69(2):236-243. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.047","DOI":"10.1016\/j.jacc.2016.10.047"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.            Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023;61(1):2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022","DOI":"10.1183\/13993003.00879-2022"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.          Kovacs G, Olschewski A, Berghold A, Olschewski H. Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J. 2012;39(2):319-328. https:\/\/doi.org\/10.1183\/09031936.00008611","DOI":"10.1183\/09031936.00008611"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.          Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34(4):888-894. https:\/\/doi.org\/10.1183\/09031936.00145608","DOI":"10.1183\/09031936.00145608"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.          Alves JL, Oleas FG, Souza R. Pulmonary Hypertension: Definition, Classification, and Diagnosis. Semin Respir Crit Care Med. 2017;38(5):561-570. https:\/\/doi.org\/10.1055\/s-0037-1606577","DOI":"10.1055\/s-0037-1606577"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.          Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387. https:\/\/doi.org\/10.1378\/chest.09-1140","DOI":"10.1378\/chest.09-1140"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.          Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary Arterial Hypertension in France: Results from a National Registry. Am J Respir Crit Care Med. 2006;173(9):1023-1030. https:\/\/doi.org\/10.1164\/rccm.200510-1668OC","DOI":"10.1164\/rccm.200510-1668OC"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.          Taichman DB, McGoon MD, Harhay MO, Archer-Chicko C, Sager JS, Murugappan M, et al. Wide variation in clinicians\u2019 assessment of New York Heart Association\/World Health Organization functional class in patients with pulmonary arterial hypertension. Mayo Clin Proc. 2009;84(7):586-592. https:\/\/doi.org\/10.1016\/S0025-6196(11)60747-7","DOI":"10.4065\/84.7.586"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.          Hoette S, Jardim C, Souza Rd. Diagnosis and treatment of pulmonary hypertension: an update. J Bras Pneumol. 2010;36(6):795-811. https:\/\/doi.org\/10.1590\/S1806-37132010000600018","DOI":"10.1590\/S1806-37132010000600018"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.          Barbosa EJM, Gupta NK, Torigian DA, Gefter WB. Current role of imaging in the diagnosis and management of pulmonary hypertension. AJR Am J Roentgenol. 2012;198(6):1320-1331. https:\/\/doi.org\/10.2214\/AJR.11.7366","DOI":"10.2214\/AJR.11.7366"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.          Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest. 2002;122(2):524-527. https:\/\/doi.org\/10.1378\/chest.122.2.524","DOI":"10.1378\/chest.122.2.524"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.          Ratanawatkul P, Oh A, Richards JC, Swigris JJ. Performance of pulmonary artery dimensions measured on high-resolution computed tomography scan for identifying pulmonary hypertension. ERJ Open Res. 2020;6(1):00232-2019. https:\/\/doi.org\/10.1183\/23120541.00232-2019","DOI":"10.1183\/23120541.00232-2019"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.          Goerne H, Batra K, Rajiah P. Imaging of pulmonary hypertension: an update. Cardiovasc Diagn Ther. 2018;8(3):279-296. https:\/\/doi.org\/10.21037\/cdt.2018.01.10","DOI":"10.21037\/cdt.2018.01.10"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.          Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53(1):1801904. https:\/\/doi.org\/10.1183\/13993003.01904-2018","DOI":"10.1183\/13993003.01904-2018"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22.          Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713; quiz 786-788. https:\/\/doi.org\/10.1016\/j.echo.2010.05.010","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.          Jones N, Burns AT, Prior DL. Echocardiographic Assessment of the Right Ventricle-State of the Art. Heart Lung Circ. 2019;28(9):1339-1350. https:\/\/doi.org\/10.1016\/j.hlc.2019.04.016","DOI":"10.1016\/j.hlc.2019.04.016"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24.          Longobardo L, Suma V, Jain R, Carerj S, Zito C, Zwicke DL, et al. Role of Two-Dimensional Speckle-Tracking Echocardiography Strain in the Assessment of Right Ventricular Systolic Function and Comparison with Conventional Parameters. J Am Soc Echocardiogr. 2017;30(10):937-946.e6. https:\/\/doi.org\/10.1016\/j.echo.2017.06.016","DOI":"10.1016\/j.echo.2017.06.016"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25.          Fauvel C, Raitiere O, Boucly A, De Groote P, Renard S, Bertona J, et al. Interest of TAPSE\/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment. J Heart Lung Transplant. 2022;41(12):1761-1772. https:\/\/doi.org\/10.1016\/j.healun.2022.09.005","DOI":"10.1016\/j.healun.2022.09.005"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.          Peacock AJ, Vonk Noordegraaf A. Cardiac magnetic resonance imaging in pulmonary arterial hypertension. Eur Respir Rev. 2013;22(130):526-534. https:\/\/doi.org\/10.1183\/09059180.00006313","DOI":"10.1183\/09059180.00006313"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.          Saunders LC, Hughes PJC, Alabed S, Capener DJ, Marshall H, Vogel-Claussen J, et al. Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension. J Magn Reson Imaging. 2022;55(3):633-652. https:\/\/doi.org\/10.1002\/jmri.27849","DOI":"10.1002\/jmri.27849"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.          Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003;41(6):1028-1035. https:\/\/doi.org\/10.1016\/S0735-1097(02)02964-9","DOI":"10.1016\/S0735-1097(02)02964-9"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29.          Hoeper MM, Dwivedi K, Pausch C, Lewis RA, Olsson KM, Huscher D, et al. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis. Lancet Respir Med. 2022;10(10):937-948. https:\/\/doi.org\/10.1016\/S2213-2600(22)00097-2","DOI":"10.1016\/S2213-2600(22)00097-2"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30.          Le Pennec R, Tromeur C, Orione C, Robin P, Le Mao R, De Moreuil C,et al. Lung Ventilation\/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use? Front Med. 2022;9:851935. https:\/\/doi.org\/10.3389\/fmed.2022.851935","DOI":"10.3389\/fmed.2022.851935"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31.          Wang M, Ma R, Wu D, Xiong C, He J, Wang L, et al. Value of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension: a patchy pattern to consider. Pulm Circ. 2019;9(1):2045894018816968. https:\/\/doi.org\/10.1177\/2045894018816968","DOI":"10.1177\/2045894018816968"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32.          Pezzuto B, Badagliacca R, Muratori M, Farina S, Bussotti M, Correale M, et al. Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension. Pulm Circ. 2022;12(1):e12044. https:\/\/doi.org\/10.1002\/pul2.12044","DOI":"10.1002\/pul2.12044"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33.          Weatherald J, Farina S, Bruno N, Laveneziana P. Cardiopulmonary Exercise Testing in Pulmonary Hypertension. Ann Am Thorac Soc. 2017;14(S1):S84-S92. https:\/\/doi.org\/10.1513\/AnnalsATS.201610-788FR","DOI":"10.1513\/AnnalsATS.201610-788FR"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34.          Ferreira EV, Ota-Arakaki JS, Ramos RP, Barbosa PB, Almeida M, Treptow EC, et al. Optimizing the evaluation of excess exercise ventilation for prognosis assessment in pulmonary arterial hypertension. Eur J Prev Cardiol. 21(11):1409-19. https:\/\/doi.org\/10.1177\/2047487313494293","DOI":"10.1177\/2047487313494293"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35.          Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903-75. https:\/\/doi.org\/10.1183\/13993003.01032-2015","DOI":"10.1183\/13993003.01032-2015"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"36.          Humbert M, Weatherald J. Right heart catheterisation is still a fundamental part of the follow-up assessment of pulmonary arterial hypertension. Eur Respir J. 2018;52(1):1800738. https:\/\/doi.org\/10.1183\/13993003.00738-2018","DOI":"10.1183\/13993003.00738-2018"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"37.          Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, et al. Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers. J Am Coll Cardiol. 2006;48(12):2546-2552. https:\/\/doi.org\/10.1016\/j.jacc.2006.07.061","DOI":"10.1016\/j.jacc.2006.07.061"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38.          Kelly CR, Rabbani LE. Pulmonary-Artery Catheterization. N Engl J Med. 2013;369(25):e35. https:\/\/doi.org\/10.1056\/NEJMvcm1212416","DOI":"10.1056\/NEJMvcm1212416"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"39.          Wilkinson JL. Haemodynamic calculations in the catheter laboratory. Heart. 2001;85(1):113-120. https:\/\/doi.org\/10.1136\/heart.85.1.113","DOI":"10.1136\/heart.85.1.113"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"40.          Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart catheterisation. Eur Respir J. 2013;42(6):1586-1594. https:\/\/doi.org\/10.1183\/09031936.00050713","DOI":"10.1183\/09031936.00050713"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41.          Kovacs G, Dumitrescu D, Barner A, Greiner S, Gr\u00fcnig E, Hager A, et al. Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:11-19. https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.083","DOI":"10.1016\/j.ijcard.2018.08.083"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"42.          Boerrigter BG, Waxman AB, Westerhof N, Vonk-Noordegraaf A, Systrom DM. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J. 2014;43(5):1316-1325. https:\/\/doi.org\/10.1183\/09031936.00016913","DOI":"10.1183\/09031936.00016913"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"43.          Viray MC, Bonno EL, Gabrielle ND, Maron BA, Atkins J, Amoroso NS, et al. Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study. Circ Heart Fail. 2020;13(11):e007981. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007981","DOI":"10.1161\/CIRCHEARTFAILURE.120.007981"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"44.          Oliveira RK, Ferreira EV, Ramos RP, Messina CM, Kapins CE, Silva CM, et al. Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension. J Heart Lung Transplant. 2014;33(2):157-162. https:\/\/doi.org\/10.1016\/j.healun.2013.10.008","DOI":"10.1016\/j.healun.2013.10.008"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"45.          Opotowsky AR, Hess E, Maron BA, Brittain EL, Bar\u00f3n AE, Maddox TM, et al. Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University. JAMA Cardiol. 2017;2(10):1090-1099. https:\/\/doi.org\/10.1001\/jamacardio.2017.2945","DOI":"10.1001\/jamacardio.2017.2945"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"46.          Hoeper MM, Maier R, Tongers J, Niedermeyer J, Hohlfeld JM, Hamm M, et al. Determination of Cardiac Output by the Fick Method, Thermodilution, and Acetylene Rebreathing in Pulmonary Hypertension. Am J Respir Crit Care Med. 1999;160(2):535-541. https:\/\/doi.org\/10.1164\/ajrccm.160.2.9811062","DOI":"10.1164\/ajrccm.160.2.9811062"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"47.          Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Ver. 2015;24(138):642-652. https:\/\/doi.org\/10.1183\/16000617.0062-2015","DOI":"10.1183\/16000617.0062-2015"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"48.          D\u2019Alto M, Dimopoulos K, Coghlan JG, Kovacs G, Rosenkranz S, Naeije R. Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Controversies and Practical Issues. Heart Fail Clin. 2018;14(3):467-477. https:\/\/doi.org\/10.1016\/j.hfc.2018.03.011","DOI":"10.1016\/j.hfc.2018.03.011"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"49.          Sitbon O, Humbert M, Ja\u00efs X, Ioos V, Hamid AM, Provencher S, et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension. Circulation. 2005;111(23):3105-3111. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.488486","DOI":"10.1161\/CIRCULATIONAHA.104.488486"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"50.          Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol. 2000;35(1):176-182. https:\/\/doi.org\/10.1016\/S0735-1097(99)00494-5","DOI":"10.1016\/S0735-1097(99)00494-5"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"51.          Opitz CF, Wensel R, Bettmann M, Schaffarczyk R, Linscheid M, Hetzer R, et al. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation. Eur Heart J. 2003;24(4):356-365. https:\/\/doi.org\/10.1016\/S0195-668X(02)00302-0","DOI":"10.1016\/S0195-668X(02)00302-0"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"52.          Fujimoto N, Borlaug BA, Lewis GD, Hastings JL, Shafer KM, Bhella PS, et al. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation. 2013;127(1):55-62. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.111302","DOI":"10.1161\/CIRCULATIONAHA.112.111302"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"53.          Vachi\u00e9ry JL, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, et al. Pulmonary hypertension due to left heart disease. Eur Respir J. 2019;53(1):1801897. https:\/\/doi.org\/10.1183\/13993003.01897-2018","DOI":"10.1183\/13993003.01897-2018"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"54.          Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, et al. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J. 2017;50(5):1700578. https:\/\/doi.org\/10.1183\/13993003.00578-2017","DOI":"10.1183\/13993003.00578-2017"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"55.          Huang W, Resch S, Oliveira RK, Cockrill BA, Systrom DM, Waxman AB. Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center. Eur J Prev Cardiol. 2017;24(11):1190-1199. https:\/\/doi.org\/10.1177\/2047487317709605","DOI":"10.1177\/2047487317709605"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"56.          Oliveira RKF, Faria-Urbina M, Maron BA, Santos M, Waxman AB, Systrom DM. Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure. Pulm Circ. 2017;7(3):654-665. https:\/\/doi.org\/10.1177\/2045893217709025","DOI":"10.1177\/2045893217709025"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"57.          Eisman AS, Shah RV, Dhakal BP, Pappagianopoulos PP, Wooster L, Bailey C, et al. Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure. Circ Heart Fail. 2018;11(5) e004750. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004750","DOI":"10.1161\/CIRCHEARTFAILURE.117.004750"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"58.          Borlaug BA, Nishimura RA, Sorajja P, Lam CSP, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3(5):588-595. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.930701","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"59.          Singh I, Rahaghi FN, Naeije R, Oliveira RKF, Systrom DM, Waxman AB. Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction. Chest. 2019;156(5):933-943. https:\/\/doi.org\/10.1016\/j.chest.2019.04.109","DOI":"10.1016\/j.chest.2019.04.109"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"60.          Lau EM, Godinas L, Sitbon O, Montani D, Savale L, Ja\u00efs X, Lador F, et al. Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics. Eur Respir J. 2016;47(5):1436-1444. https:\/\/doi.org\/10.1183\/13993003.01684-2015","DOI":"10.1183\/13993003.01684-2015"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"61.          Oliveira RK, Agarwal M, Tracy JA, Karin AL, Opotowsky AR, Waxman AB, et al. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics. Eur Respir J. 2016;47(4):1179-1188. https:\/\/doi.org\/10.1183\/13993003.01307-2015","DOI":"10.1183\/13993003.01307-2015"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"62.          Zeder K, Avian A, Bachmaier G, Douschan P, Foris V, Sassmann T, et al. Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis. Chest. 2021;159(2):781-790. https:\/\/doi.org\/10.1016\/j.chest.2020.08.2110","DOI":"10.1016\/j.chest.2020.08.2110"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"63.          Messina CMS, Ferreira EVM, Singh I, Fonseca AXC, Ramos RP, Nery LE, et al. Impact of right ventricular work and pulmonary arterial compliance on peak exercise oxygen uptake in idiopathic pulmonary arterial hypertension. Int J Cardiol. 2021;331:230-235. https:\/\/doi.org\/10.1016\/j.ijcard.2021.01.027","DOI":"10.1016\/j.ijcard.2021.01.027"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"64.          Guth S, Wiedenroth CB, Rieth A, Richter MJ, Gruenig E, Ghofrani HA, et al. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease. Eur Respir J. 2018;52(3):1800458. https:\/\/doi.org\/10.1183\/13993003.00458-2018","DOI":"10.1183\/13993003.00458-2018"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"65.          Soubrier F, Chung WK, Machado R, et al. Genetics and Genomics of Pulmonary Arterial Hypertension. J Am Coll Cardiol 2013;62(25):D13-D21. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.035","DOI":"10.1016\/j.jacc.2013.10.035"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"66.          Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4(4):306-322. https:\/\/doi.org\/10.1016\/S2213-2600(15)00543-3","DOI":"10.1016\/S2213-2600(15)00543-3"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"67.          Montani D, Lau EM, Dorfm\u00fcller P, Girerd B, Ja\u00efs X, Savale L, et al. Pulmonary veno-occlusive disease. Eur Respir J. 2016;47(5):1518-1534. https:\/\/doi.org\/10.1183\/13993003.00026-2016","DOI":"10.1183\/13993003.00026-2016"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"68.          Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet. 2014;46(1):65-69. https:\/\/doi.org\/10.1038\/ng.2844","DOI":"10.1038\/ng.2844"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"69.          Boucly A, Weatherald J, Savale L, Ja\u00efs X, Cottin V, Prevot G, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017;50(2):1700889. https:\/\/doi.org\/10.1183\/13993003.00889-2017","DOI":"10.1183\/13993003.00889-2017"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"70.          Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50(2):1700740. https:\/\/doi.org\/10.1183\/13993003.00740-2017","DOI":"10.1183\/13993003.00740-2017"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"71.          Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Gr\u00fcnig E, et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2022;60(1): 2102311. https:\/\/doi.org\/10.1183\/13993003.02311-2021","DOI":"10.1183\/13993003.02311-2021"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"72.          Benza RL, Gomberg-Maitland M, Miller DP, Frost A, Frantz RP, Foreman AJ, et al. The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension. Chest. 2012;141(2):354-362. https:\/\/doi.org\/10.1378\/chest.11-0676","DOI":"10.1378\/chest.11-0676"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"73.          Benza RL, Kanwar MK, Raina A, Scott JV, Zhao CL, Selej M, et al. Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension. Chest. 2021;159(1):337-346. https:\/\/doi.org\/10.1016\/j.chest.2020.08.2069","DOI":"10.1016\/j.chest.2020.08.2069"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4198\/en-US","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T16:53:14Z","timestamp":1768841594000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/5203\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":73,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250065","relation":{},"ISSN":["1806-3713","1806-3713"],"issn-type":[{"value":"1806-3713","type":"print"},{"value":"1806-3713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}